The trademark application SYVIFY was filed by Johnson & Johnson, a U.S. corporation (the "Applicant"). The application was published for oppositions on August 7, 2022, and it was registered by office on November 14, 2022 without any oppositions.
The application was filed in Dutch (English was selected as the second language).
Appointment and Replacement of representative of the trademark registration was recorded on December 19, 2022.
Goods And Services
The mark was filed in class 5 with following description of goods:
Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, pulmonary diseases, cardiovascular diseases, central nervous system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, cerebrovascular diseases, ophthalmic diseases, and respiratory diseases